Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Updated page revision tag from v3.6.4 to v3.6.5, indicating a minor maintenance update. The visible content and structure of the page remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-09T09:14:09.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a routine page update and does not alter the study information.
    Difference
    0.1%
    Check dated 2026-07-25T18:24:46.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2 as part of a minor revision to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-04T10:07:31.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2. This reflects a minor system/UI update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:43:12.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and several help/navigation items were added while two formatting/version notes were removed or updated.
    Difference
    0.4%
    Check dated 2026-06-13T01:32:58.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    New site revision displayed as Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a platform update rather than changes to the study details or study content.
    Difference
    0.1%
    Check dated 2026-06-05T21:55:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.